Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2011 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Non-Current Deferred Tax Liability came in at $249.9 million in Q1 2026, up 2.38% quarter-over-quarter from $244.1 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Non-Current Deferred Tax Liability history runs 15 years deep, the most recent figure standing at $249.9 million for Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $249.9 million in Q1 2026; TTM through Mar 2026 was $249.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $244.1 million, down 30.75% from the prior year.
- Non-Current Deferred Tax Liability rose to $249.9 million in Q1 2026 per ZBH's latest filing, from $244.1 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $541.3 million in Q3 2022 and bottomed at $244.1 million in Q4 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $470.1 million (2022), against an average of $419.3 million.
- Across the five-year window, Non-Current Deferred Tax Liability tumbled 35.99% in 2022 and slipped 1.12% in 2023, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $474.8 million in 2022, then retreated by 24.68% to $357.6 million in 2023, then dropped by 1.43% to $352.5 million in 2024, then plunged by 30.75% to $244.1 million in 2025, then climbed by 2.38% to $249.9 million in 2026.
- Per Business Quant, the three latest ZBH Non-Current Deferred Tax Liability figures stand at $249.9 million (Q1 2026), $244.1 million (Q4 2025), and $352.5 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.90 Mn |
| Mar 31, 2026 | 249.90 Mn |
| Dec 31, 2025 | 244.10 Mn |
| Dec 31, 2025 | 244.10 Mn |
| Dec 31, 2024 | 352.50 Mn |
| Dec 31, 2024 | 352.50 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Dec 31, 2023 | 357.60 Mn |
| Dec 31, 2023 | 357.60 Mn |
| Sep 30, 2023 | 465.40 Mn |
| Sep 30, 2023 | 465.40 Mn |
| Jun 30, 2023 | 474.90 Mn |
| Jun 30, 2023 | 474.90 Mn |
| Mar 31, 2023 | 484.60 Mn |
| Mar 31, 2023 | 484.60 Mn |
| Dec 31, 2022 | 474.80 Mn |
| Dec 31, 2022 | 474.80 Mn |
| Sep 30, 2022 | 541.30 Mn |
| Sep 30, 2022 | 541.30 Mn |